Adrienne Lugo

Adrienne Lugo has over 20 years of leadership experience in women’s health and molecular diagnostics, with a strong track record of building high-performing teams, expanding market access, and partnering with physicians and health systems to deliver innovative testing solutions. Adrienne has served in commercial leadership roles at BillionToOne and Bayer Healthcare, where she was instrumental in driving growth and advancing adoption of novel diagnostic technologies. As Head of Sales and Strategic Accounts, Adrienne leads the company’s commercial strategy and key partnerships to support continued growth and broader adoption of Sera’s technology. Her deep expertise and strategic approach will be critical as the company expands its impact on maternal and fetal health. Adrienne began her career in healthcare sales and has held roles of increasing responsibility across the diagnostics and life sciences sectors, consistently delivering strong results in competitive and evolving markets. Adrienne is the proud mother of three children (triplets) and resides in Tampa with her family and rescue dog. She is driven by a strong sense of purpose, which aligns closely with Sera’s mission to improve pregnancy outcomes for mothers and babies.